Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Gains from Investment Securities (2020 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Gains from Investment Securities for 7 consecutive years, with $84000.0 as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities changed N/A year-over-year to $84000.0; the TTM value through Mar 2026 reached $956000.0, down 18.43%, while the annual FY2025 figure was $200000.0, 76.91% down from the prior year.
  • Gains from Investment Securities hit $84000.0 in Q1 2026 for Barinthus Biotherapeutics, down from $522000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $6.8 million in Q2 2023 and bottomed at -$31000.0 in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $2.1 million, with a median of $522000.0 recorded in 2025.
  • Year-over-year, Gains from Investment Securities skyrocketed 43665.21% in 2022 and then crashed 101.51% in 2023.
  • Barinthus Biotherapeutics' Gains from Investment Securities stood at $2.1 million in 2022, then plummeted by 101.51% to -$31000.0 in 2023, then soared by 3880.65% to $1.2 million in 2024, then plummeted by 55.46% to $522000.0 in 2025, then crashed by 83.91% to $84000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $84000.0, $522000.0, and $50000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.